Triplet Induction + 1 or 2-Drug Maintenance

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

Near Add Your Location

Holden Comprehensive Cancer Center - University of Iowa
University of Iowa Hospitals and Clinics
Iowa City, IA
  • Accepting patients
City of Hope Comprehensive Cancer Center
Beckman Research Institute
Duarte, CA
  • Accepting patients
University of Rochester Medical Center Wilmot Cancer Center
Strong Memorial Hospital
Rochester, NY
  • Accepting patients
Loyola University Medical Center
Cardinal Bernardin Cancer Center
Maywood, IL
  • Accepting patients
IU Health Hematology & Oncology
IU Health North Hospital
Carmel, IN
  • Accepting patients
Barbara Ann Karmanos Cancer Institute
Wayne State University
Detroit, MI
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.